Log in or Sign up for Free to view tailored content for your specialty!
Infection News
FDA: Evusheld no longer authorized to prevent COVID-19 in US ‘until further notice’
Evusheld is no longer authorized for use to help prevent COVID-19 in the United States “until further notice,” due to a lack of protection against dominant variants, according to new guidance issued by the FDA.
Self-reporting platform may improve quality of life in long COVID, autoimmune diseases
A self-evidence data platform may help patients with autoimmune diseases and long COVID avoid certain lifestyle and environmental triggers, according to a press release.
Log in or Sign up for Free to view tailored content for your specialty!
Vaccinated patients with SARDs less likely to exhibit lingering COVID-19 symptoms
Patients with systemic autoimmune rheumatic diseases who are fully vaccinated against COVID-19 are less likely to experience long COVID symptoms, compared with unvaccinated patients, according to data.
EULAR: Screen for TB, other infections in patients starting DMARDs
Patients with autoimmune inflammatory rheumatic diseases should be screened for tuberculosis, hepatitis B and other infections before starting disease-modifying antirheumatic drugs, according to new guidelines published by EULAR.
IgA vasculitis risk following COVID-19 vaccine no greater than with other vaccines
Patients who have received a COVID-19 vaccine demonstrate a “slight but significant” change of developing IgA vasculitis, but no more than with other vaccines, according to data published in the Journal of Rheumatology.
Patients with IMIDs, hybrid immunity may be able to delay fourth COVID-19 vaccine dose
Patients with immune-mediated inflammatory disease undergoing immunosuppressive therapy gain a “significant immunological boost” following SARS-CoV-2 infection, according to data published in The Lancet Rheumatology.
Kawasaki disease diagnoses fell one-third in Japan during first year of COVID pandemic
The number of patients diagnosed with Kawasaki disease in Japan fell by approximately one-third in 2020, with no indication that parents eschewed necessary hospital visits, according to data published in JAMA Pediatrics.
Black, Hispanic patients with lupus have worse COVID-19 outcomes than white patients
Black and Hispanic patients with systemic lupus erythematous demonstrate more severe COVID-19 outcomes than white patients, according to data published in Arthritis Care & Research.
Persistent positive ANA tests 1 year after COVID-19 may predict long COVID symptoms
Consistently positive antinuclear antibody tests at 12 months following acute SARS-CoV-2 infection may predict long-term symptoms and inflammation, according to data published in the European Respiratory Journal.
COVID-19 pandemic reduced access to optimal lupus care, providers report
Health care professionals around the world are reporting that the COVID-19 pandemic has prevented patients with systemic lupus erythematosus from receiving optimal care, resulting in increased risk for organ damage, according to a survey.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read